• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Development and Qualification of a Pseudotyped Virus-Based Microneutralisation Assay for Influenza D Virus

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2026 Apr;20(4):e70245.
doi: 10.1111/irv.70245.
Development and Qualification of a Pseudotyped Virus-Based Microneutralisation Assay for Influenza D Virus

Maria Giovanna Marotta[SUP] 1 2 3 [/SUP], Tobias Mapulanga[SUP] 1 [/SUP], Meshach Maina[SUP] 4 [/SUP], Janet Daly[SUP] 4 [/SUP], Michele Camero[SUP] 5 [/SUP], Pauline Mvan Diemen[SUP] 6 [/SUP], Helen E Everett[SUP] 6 [/SUP], Emanuele Montomoli[SUP] 2 7 [/SUP], Kelly da Costa[SUP] 1 [/SUP], Nigel Temperton[SUP] 1 [/SUP], Claudia Maria Trombetta[SUP] 2 [/SUP]


Affiliations
Abstract

Background: Epidemiological surveillance of influenza D virus (IDV) has gained increased priority following recent serological findings indicating its potential zoonosis in humans. In this context, it is crucial to develop strong, reproducible, reliable and scalable immunological assays that can be quickly implemented in the surveillance of new emerging threats. Serology is a powerful tool for immune monitoring prior to infection and conducting epidemiological surveillance. However, the traditional microneutralisation (MN) assay requires wild-type viruses, considerably limiting its accessibility for some laboratories. Pseudotyped viruses (PVs) allow for expanded usage since they are safer and more flexible for adaptation to specific strains and enable application in laboratories without implementation in high biosecurity containment.
Methods: In this study, we conducted the qualification of a PV-based MN (pMN) assay with IDV-PVs that express the HEF glycoprotein of the D/Swine/Italy/199724-3/2015 strain. The assay functionality was examined using 14 bovine serum samples, assessing key analytical parameters including accuracy, specificity, precision, linearity and robustness.
Results: The findings demonstrate the IDV pMN assay to be an effective method for the detection of neutralising antibodies.
Conclusions: Therefore, the assay can be a valuable tool to facilitate large-scale surveillance and provide data to inform immunisation strategy development.

Keywords: accuracy; immunity; influenza D virus; linearity; precision; pseudotyped virus; qualification; robustness; specificity.

 
Back
Top